Pharmaceutical products (ammonia, solution for external use, 10%, 40 ml; ammonia, solution for external use, 10%, 100 ml; amoxicillin/clavulanic acid, film-coated tablets, 500 mg/125 mg; amoxicillin tablets/dispersible tablets, 250 mg; silver...
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
Pharmaceutical products (ammonia, solution for external use, 10%, 40 ml; ammonia, solution for external use, 10%, 100 ml; amoxicillin/clavulanic acid, film-coated tablets, 500 mg/125 mg; amoxicillin tablets/dispersible tablets, 250 mg; silver sulfadiazine, cream/ointment, 1%, 40 g; amiodarone, solution for injection, 50 mg/ml, 3 ml; acetylsalicylic acid tablets, 100 mg; beclometasone, nasal spray, 50 mcg/dose, 180 doses; betamethasone cream/ointment, 0.64 mg/g, 15 g; bisoprolol tablets, 10 mg; bisoprolol tablets, 5 mg; ibuprofen, oral suspension, 100 mg/5 ml, 100 ml; vancomycin, lyophilisate/powder for solution for infusion, 1000 mg; hydrocortisone, suspension for injection, 25 mg/ml, 2 ml; iron(III) hydroxide polymaltose complex with folic acid, tablets, 100 mg/0.35 mg; suxamethonium, solution for injection, 20 mg/ml, 5 ml; theophylline, solution for injection, 20 mg/ml, 5 ml; phytomenadione, emulsion for injection, 10 mg/ml, 1 ml; clarithromycin, film-coated tablets, 250 mg; latanoprost, eye drops, 0.05 mg/ml, 2.5 ml; levofloxacin, solution for infusion, 5 mg/ml, 100 ml; lidocaine, solution for injection, 100 mg/ml, 2 ml; linezolid, solution for infusion, 2 mg/ml, 300 ml; naloxone, solution for injection, 0.4 mg/ml, 1 ml; budesonide, suspension for nebulisation, 0.5 mg/ml, 2 ml; lactulose syrup, 3.335 g/5 ml, 200 ml bottle; oseltamivir tablets/capsules, 75 mg; oxytocin, solution for injection, 5 IU/ml; ondansetron, solution for injection, 2 mg/ml, 4 ml; ofloxacin, solution for infusion, 2 mg/ml, 100 ml; anti-D immunoglobulin human, solution for injection, 300 mcg (1500 IU)/2 ml, 2 ml; senna tablets, 70 mg; levothyroxine tablets, 100 mcg; cefixime tablets/capsules, 400 mg; clopidogrel, film-coated tablets, 75 mg; ciprofloxacin, eye/ear drops, 3 mg/ml, 5 ml; furosemide, solution for injection, 10 mg/ml, 2 ml; cyclopentolate, eye drops, 1%, 5 ml; colistin, powder for solution for injection or infusion, 1 000 000 IU; bupivacaine, solution for injection, 5 mg/ml, 20 ml; amoxicillin and clavulanic acid, powder for injection/infusion, 1.2 g; amikacin, solution for injection, 250 mg/ml, 2 ml; amikacin, solution for injection, 250 mg/ml, 4 ml (1000 mg); propofol, emulsion, 10 mg/ml, 20 ml; povidone-iodine, solution for external use, 10%, 100 ml; ceftriaxone, powder for injection, 1 g; cyanocobalamin (vitamin B12), solution for injection, 0.5 mg/ml, 1 ml; rocuronium bromide, solution for injection, 10 mg/ml, 5 ml), CPV code: 33600000-6 pharmaceutical products
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare Equipment and Services, Chemicals